Article Text

Download PDFPDF
Potential of personalised approaches in gastric cancer prevention
  1. Mārcis Leja1,2
  1. 1 Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia
  2. 2 Gastroenterology, Digestive Diseases Centre GASTRO, Riga, Latvia
  1. Correspondence to Dr Mārcis Leja, Institute of Clinical and Preventive Medicine, University of Latvia, Riga 1586, Latvia; marcis.leja{at}lu.lv

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

An effective cancer screening programme should assure high participation of the target population, while also fulfilling a number of criteria set for an organised cancer screening programme, including governance, quality assurance and auditing. Such a programme is supposed to contain mechanisms for identification of the target population as well as for inviting eligible individuals for screening.1 Traditionally, letters of invitation have been used for this purpose, nevertheless new approaches and technologies are currently getting used more in reaching the target population; furthermore, in the future, cancer screening is supposed to develop towards personalised approaches, that is, by planning the screening intervals and even methods based on the individual characteristics of the particular individual as well as the result of the preceding screening test.

Population-wide organised gastric cancer screening has so far only been run in Japan and Korea with endoscopy or double-contract photofluoroscopy.2 The Taipei global consensus report3 has been calling for the integration of population-wide screening and the eradication of Helicobacter pylori, the main causative factor of gastric cancer into the national healthcare priorities. Recently, the European Council has also recommended the implementation of gastric cancer prevention by screening for and eradicating H. pylori in high-risk populations of Europe. …

View Full Text

Footnotes

  • Contributors The manuscript is solely the work of the author.

  • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles